Psilocin Pharma - Ownership and Business Overview

Life ScienceCompany

Psilocin Pharma Ownership

Who owns Psilocin Pharma?

Psilocin Pharma is owned by Revive Therapeutics. It was acquired on February 12, 2020.

Psilocin Pharma Business Overview

Where is Psilocin Pharma headquartered?

Psilocin Pharma is headquartered in Toronto, Ontario.

What sector is Psilocin Pharma in?

Psilocin Pharma is a life science company.

Life Science M&A Summary in 2020

Out of 60 sectors in the Mergr database, life science ranked 6 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.

Join Mergr to view all 282 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 259 by strategics.

Psilocin Pharma Corp.

Toronto, Ontario
Canada,
www.psilocinpharma.com

Psilocin Pharma Corp. has developed production solutions for the active compound Psilocybin. Psilocin process encompassed with intellectual property cover methods of production of Psilocybin based formulations. Psilocin had developed 6 formulations to date. Psilocin Pharma Corp’s range of products has been engineered to work synergistically with the body's own natural pathways of absorption while offering a contemporary approach to consumption.


 Subscribe to unlock this and 201,882
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.